Filing Details
- Accession Number:
- 0001209191-10-052947
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-03 16:42:51
- Reporting Period:
- 2010-11-01
- Filing Date:
- 2010-11-03
- Accepted Time:
- 2010-11-03 16:42:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333248 | Cadence Pharmaceuticals Inc | CADX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244823 | B James Breitmeyer | C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive, Suite 200 San Diego CA 92130 | Evp, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-01 | 7,000 | $3.20 | 17,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-01 | 7,000 | $9.00 | 10,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-11-02 | 18,000 | $3.20 | 28,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-02 | 18,000 | $9.05 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | stock option (right to buy) | Disposition | 2010-11-01 | 7,000 | $0.00 | 7,000 | $3.20 |
| Common Stock | stock option (right to buy) | Disposition | 2010-11-02 | 18,000 | $0.00 | 18,000 | $3.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 147,250 | 2006-08-14 | 2016-08-13 | No | 4 | M | Direct |
| 129,250 | 2006-08-14 | 2016-08-13 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2010.
- This transaction was executed in multiple trades at prices ranging from a low of $8.95 to a high of $9.23. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Not applicable to this transaction.
Billionaire Hedge Funds
